Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin: An in vivo model relevant to Parkinson's disease

Seong Who Kim, Yeon Joo Jang, JinWoo Chang, Onyou Hwang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We determined whether the preferential toxicity of tetrahydrobiopterin (BH4) on dopamine-producing cells, which we have previously observed in vitro, might also occur in vivo and generate characteristics associated with Parkinson's disease. Intrastriatal BH4 injection caused a loss of tyrosine hydroxylase immunoreactivity and decreased dopamine content. The dopaminergic cell bodies topologically corresponding to the lesioned terminals were selectively degenerated. This was accompanied by a dose-dependent and asymmetric movement deficit in the contralateral forepaw. Direct injection of BH4 into the substantia nigra caused a loss of tyrosine hydroxylase immunoreactivity, but injection into the dorsal raphe was without effect on the GTP cyclohydrolase-immunoreactive serotonergic neurons, demonstrating selectivity for the dopaminergic system. BH4 exhibited a range of potency comparable to that of 6-hydroxydopamine. Thus, this animal model generated by the administration of BH4, the molecule endogenously present in the monoaminergic neurons, exhibited morphological, biochemical, and behavioral characteristics associated with Parkinson's disease and may be useful for studies in dopaminergic degeneration.

Original languageEnglish
Pages (from-to)167-176
Number of pages10
JournalNeurobiology of Disease
Volume13
Issue number2
DOIs
Publication statusPublished - 2003 Jan 1

Fingerprint

Efferent Pathways
Parkinson Disease
Tyrosine 3-Monooxygenase
Injections
Dopamine
GTP Cyclohydrolase
Serotonergic Neurons
Oxidopamine
Substantia Nigra
Animal Models
Neurons
sapropterin

All Science Journal Classification (ASJC) codes

  • Neurology

Cite this

@article{b6f6a5e6f69c476ea30c400cbf8fc68f,
title = "Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin: An in vivo model relevant to Parkinson's disease",
abstract = "We determined whether the preferential toxicity of tetrahydrobiopterin (BH4) on dopamine-producing cells, which we have previously observed in vitro, might also occur in vivo and generate characteristics associated with Parkinson's disease. Intrastriatal BH4 injection caused a loss of tyrosine hydroxylase immunoreactivity and decreased dopamine content. The dopaminergic cell bodies topologically corresponding to the lesioned terminals were selectively degenerated. This was accompanied by a dose-dependent and asymmetric movement deficit in the contralateral forepaw. Direct injection of BH4 into the substantia nigra caused a loss of tyrosine hydroxylase immunoreactivity, but injection into the dorsal raphe was without effect on the GTP cyclohydrolase-immunoreactive serotonergic neurons, demonstrating selectivity for the dopaminergic system. BH4 exhibited a range of potency comparable to that of 6-hydroxydopamine. Thus, this animal model generated by the administration of BH4, the molecule endogenously present in the monoaminergic neurons, exhibited morphological, biochemical, and behavioral characteristics associated with Parkinson's disease and may be useful for studies in dopaminergic degeneration.",
author = "Kim, {Seong Who} and Jang, {Yeon Joo} and JinWoo Chang and Onyou Hwang",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0969-9961(03)00037-8",
language = "English",
volume = "13",
pages = "167--176",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "2",

}

Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin : An in vivo model relevant to Parkinson's disease. / Kim, Seong Who; Jang, Yeon Joo; Chang, JinWoo; Hwang, Onyou.

In: Neurobiology of Disease, Vol. 13, No. 2, 01.01.2003, p. 167-176.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin

T2 - An in vivo model relevant to Parkinson's disease

AU - Kim, Seong Who

AU - Jang, Yeon Joo

AU - Chang, JinWoo

AU - Hwang, Onyou

PY - 2003/1/1

Y1 - 2003/1/1

N2 - We determined whether the preferential toxicity of tetrahydrobiopterin (BH4) on dopamine-producing cells, which we have previously observed in vitro, might also occur in vivo and generate characteristics associated with Parkinson's disease. Intrastriatal BH4 injection caused a loss of tyrosine hydroxylase immunoreactivity and decreased dopamine content. The dopaminergic cell bodies topologically corresponding to the lesioned terminals were selectively degenerated. This was accompanied by a dose-dependent and asymmetric movement deficit in the contralateral forepaw. Direct injection of BH4 into the substantia nigra caused a loss of tyrosine hydroxylase immunoreactivity, but injection into the dorsal raphe was without effect on the GTP cyclohydrolase-immunoreactive serotonergic neurons, demonstrating selectivity for the dopaminergic system. BH4 exhibited a range of potency comparable to that of 6-hydroxydopamine. Thus, this animal model generated by the administration of BH4, the molecule endogenously present in the monoaminergic neurons, exhibited morphological, biochemical, and behavioral characteristics associated with Parkinson's disease and may be useful for studies in dopaminergic degeneration.

AB - We determined whether the preferential toxicity of tetrahydrobiopterin (BH4) on dopamine-producing cells, which we have previously observed in vitro, might also occur in vivo and generate characteristics associated with Parkinson's disease. Intrastriatal BH4 injection caused a loss of tyrosine hydroxylase immunoreactivity and decreased dopamine content. The dopaminergic cell bodies topologically corresponding to the lesioned terminals were selectively degenerated. This was accompanied by a dose-dependent and asymmetric movement deficit in the contralateral forepaw. Direct injection of BH4 into the substantia nigra caused a loss of tyrosine hydroxylase immunoreactivity, but injection into the dorsal raphe was without effect on the GTP cyclohydrolase-immunoreactive serotonergic neurons, demonstrating selectivity for the dopaminergic system. BH4 exhibited a range of potency comparable to that of 6-hydroxydopamine. Thus, this animal model generated by the administration of BH4, the molecule endogenously present in the monoaminergic neurons, exhibited morphological, biochemical, and behavioral characteristics associated with Parkinson's disease and may be useful for studies in dopaminergic degeneration.

UR - http://www.scopus.com/inward/record.url?scp=0038048460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038048460&partnerID=8YFLogxK

U2 - 10.1016/S0969-9961(03)00037-8

DO - 10.1016/S0969-9961(03)00037-8

M3 - Article

C2 - 12828940

AN - SCOPUS:0038048460

VL - 13

SP - 167

EP - 176

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 2

ER -